Related Experiment Videos
HLA-G and lymphoproliferative disorders.
Laurence Amiot1, Gaëlle Le Friec, Yasmine Sebti
1Laboratoire Universitaire d'Hématologie et de la Biologie des Cellules Sanguines, UPRES EA 22-33, Faculté de Médecine, Université de Rennes 1, Rennes, France. laurence.amiot@chu-rennes.fr
Seminars in Cancer Biology
|January 8, 2004
Summary
Human Leukocyte Antigen-G (HLA-G) plays a role in immune evasion in lymphoproliferative disorders. Investigations reveal varied HLA-G mRNA, rare cell surface expression, and increased soluble HLA-G in serum.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The Human Leukocyte Antigen-G (HLA-G) molecule possesses immunomodulatory properties, making it relevant in various malignancies.
- Understanding HLA-G expression is crucial for deciphering immune evasion mechanisms in cancers.
Purpose of the Study:
- To investigate the expression and distribution of HLA-G and its isoforms in lymphoproliferative disorders.
- To explore the potential role of HLA-G, particularly its soluble form, in immune evasion within these malignancies.
Main Methods:
- Analysis of alternatively spliced HLA-G mRNA isoforms.
- Assessment of cell surface HLA-G expression in diffuse large cell lymphomas.
- Quantification of soluble HLA-G (sHLA-G) levels in serum.
Main Results:
- A frequent and variable distribution of alternatively spliced HLA-G mRNA isoforms was observed.
- Cell surface HLA-G expression was rare in diffuse large cell lymphomas, often coinciding with HLA class I loss.
- Increased serum levels of soluble HLA-G were detected in approximately half of the cases.
Conclusions:
- The findings suggest that HLA-G, especially its soluble isoform, may facilitate immune evasion in lymphoid proliferations.
- The microenvironment and tumoral processes likely influence HLA-G expression in these disorders.
- Soluble HLA-G represents a potential therapeutic target for overcoming immune evasion in lymphoproliferative disorders.